On Thursday 19 October, more than 100 people attended the second ‘Future of Cancer Treatment’ event at the Queen Elizabeth Hospital Birmingham (QEHB).
The event featured several presentations on topics as varied as personalised medicine, big data, ethical considerations, and opportunities for cancer research.
After a short interval, there was a lively Q and A session, chaired by Professor Dion Morton, Director of the West Midlands Genomic Medicine Centre (WMGMC).
The event was organised by a local Cancer Research team (CRUK), and QEHB.
Audience feedback was extremely positive, with many commenting favourably on the quality of debate and range of supporting information available, in leaflets and flyers.
Janette Rawlinson’s talk on “What might personalised medicine mean for the patient?” was particularly well-received, offering a patient’s perspective on cancer treatment.
Debbie Ringham, Research Engagement Manager for Birmingham and the Midlands at CRUK, said: “It was great to see so many people at our second ‘Future of Cancer Treatment’ event.”
“There are really exciting developments happening with cancer medicine and treatment, such as whole genome sequencing and better diagnostics helping patients be diagnosed earlier.”
“I’d like to thank all our speakers and attendees for making the event such a success.”
The WMGMC is one of 13 centres nationwide supporting the 100k Genomes Project, and involves 17 NHS Trusts across the region.
The pioneering project aims to improve diagnosis and treatment of rare diseases and cancer by sequencing 100,000 whole genomes – a person’s entire genetic code – from patients with certain rare conditions and their families as well as those with certain cancers.
Further details on the next ‘Future of Cancer Treatment’ event will be announced soon.
If you would like any further information, please contact Debbie Ringham or Tom Hammond.